NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2

Monte, Thais L.; Reckziegel, Estela R.; Augustin, Marina C.; Silva, Amanda S. P.; Coelho, Lucas D. Locks; Barsottini, Orlando; Pedroso, José L.; Vargas, Fernando R.; Pereira, Maria Luiza Saraiva-; Leotti, Vanessa Bielefeldt; Jardim, Laura Bannach.
Artículo en Inglés | ARCA | ID: arc-23458

Documentos relacionados

  1. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
  2. Pre-ataxic Changes of Clinical Scales and Eye Movement in Machado-Joseph Disease: BIGPRO Study.
  3. A new species of Apostolepis (Serpentes, Dipsadidae, Elapomorphini) from the Cerrado of Central Brazil
  4. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
  5. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.
  6. Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia.
  7. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
  8. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.
  9. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
  10. Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy.